RPS6KB1 and breast carcinoma: Kalyana-Sundaram et al.41 have also reported that amplicon-associated EGFR or RPS6KB1 fusion transcripts without a kinase domain represented low TAF values and were passenger aberrations in breast cancer cell lines.